Skip to main content
. 2022 Apr 29;11(9):2520. doi: 10.3390/jcm11092520

Table 1.

Intubation characteristics of patients in the cohort study stratified by extubation outcomes.

Characteristics Total Cohort
(n = 499)
Uneventful
Extubation
(n = 328) a
Noninvasive
Respiratory
Support
(n = 125) b
Reintubation
(n = 46)
p Value Missing
(%)
Age, years 69 (55–77) 69 (55–77) 69 (54–78) 70 (63–76) 0.913 0
Male sex, n (%) 311 (62.3%) 201 (61.3%) 79 (63.2%) 31 (67.4%) 0.706 0
Body mass index, kg/m2 22.5 (19.8–25.4) 22.2 (19.8–25.2) 23.7 (20.1–26.7) 21.0 (19.0–24.0) 0.025 0
APACHE II score 19 (14–24) 19 (14–23) 19 (14–25) 18 (14–22) 0.386 0
Comorbidity, n (%)
 Heart failure 151 (30.3%) 94 (28.7%) 45 (36.0%) 12 (26.1%) 0.194 0
 COPD 33 (6.6%) 18 (5.5%) 11 (8.8%) 4 (8.7%) 0.375 0
 Asthma 23 (4.6%) 15 (4.6%) 6 (4.8%) 2 (4.3%) 0.991 0
 Other respiratory diseases 66 (13.2%) 37 (11.3%) 18 (14.4%) 11 (23.9%) 0.300 0
 Diabetes mellitus 130 (26.1%) 82 (25.0%) 33 (26.4%) 15 (32.6%) 0.543 0
 Chronic kidney disease 101 (20.2%) 66 (20.1%) 23 (18.4%) 12 (26.1%) 0.538 0
Surgical ICU admission, n (%) 355 (71.1%) 224 (68.3%) 93 (74.4%) 38 (82.6%) 0.087 0
Reason for mechanical ventilation, n (%)
 Asthma 2 (0.4%) 2 (0.6%) 0 (0.0%) 0 (0.0%) 0.096 0
 COPD 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%)
 Pneumonia 50 (10.0%) 33 (10.0%) 9 (7.2%) 8 (17.4%)
 ARDS 4 (0.8%) 3 (0.9%) 1 (0.8%) 0 (0.0%)
 Postoperative acute respiratory failure 329 (65.9%) 207 (63.1%) 88 (70.4%) 34 (73.9%)
 Upper airway obstruction 4 (0.8%) 3 (0.9%) 1 (0.8%) 0 (0.0%)
 Other causes of respiratory failure 17 (3.4%) 10 (3.0%) 6 (4.8%) 1 (2.2%)
 Sepsis 23 (4.6%) 17 (5.2%) 4 (3.2%) 2 (4.3%)
 Heart failure 29 (5.8%) 21 (6.4%) 8 (6.4%) 0 (0.0%)
 Coma 12 (2.4%) 8 (2.4%) 3 (2.4%) 1 (2.2%)
 Neurological disease 10 (2.0%) 9 (2.7%) 1 (0.8%) 0 (0.0%)
 Trauma 1 (0.2%) 0 (0.0%) 1 (0.8%) 0 (0.0%)
 Cardiac arrest 18 (3.6%) 15 (4.6%) 3 (2.4%) 0 (0.0%)

Data are expressed as medians (interquartile range) or n (%). a Uneventful extubation was defined as the non-requirement of reintubation or noninvasive respiratory support within 48 h post extubation. b Patients in the noninvasive respiratory support group were administered NIV or HFNO within 48 h post extubation (without reintubation). APACHE Acute Physiology and Chronic Health Evaluation, COPD chronic obstructive pulmonary disease, ICU intensive care unit, ARDS acute respiratory distress syndrome, NIV noninvasive ventilation, HFNO high-flow nasal oxygen.